Adjuvant Chemoradiation for Gastric Cancer: Experience in the Chinese Population

Clinical Oncology

Volumn 19, Issue 5, 2007, Pages 333-340

  Tsang, W K ^a   Leung, S F ^b   Chiu, S K W ^a   Yeung, W W K ^a   Ng, E K W ^b   Yeo, W ^b   Lam, K C ^a   Chiu, P W Y ^b   Ma, B B Y ^b   Kwan, W H ^a   Chan, A T C ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c NONE

Author keywords

Chemotherapy; computed tomography planning; conformal radiotherapy; gastric cancer; organs at risk; prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ANTERIOR POSTERIOR AXIS; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CHINESE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HISTOPATHOLOGY; HONG KONG; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEPSIS; STOMACH ADENOCARCINOMA; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34248587188     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.03.004     Document Type: Article

References (27)

1. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
2. Macdonald J.S., Smalley S.R., Benedetti J., et al. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: update of the results of Intergroup Study INT-0116 (SWOG 9008). Proc Am Soc Clin Oncol GI Cancer Symposium (2004) (abstract 6)
3. Verheij M., Oppedijk V., Boot H., et al. Late renal toxicity following post-operative chemoradiotherapy in gastric cancer. Proc Am Soc Clin Oncol GI Cancer Symposium (2005) (abstract 2)
4. Tepper J.E., and Gunderson L.L. Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer. Semin Radiat Oncol 12 (2002) 187-195
5. Leong T., Willis D., Joon D.L., et al. 3D conformal radiotherapy for gastric cancer: results of a comparative planning study. Radiother Oncol 74 (2005) 301-306
6. Kassam Z., Lockwood G., O'Brien C., et al. Conformal radiotherapy in adjuvant treatment of gastric cancer: review of 82 cases. Int J Radiat Oncol Biol Phys 65 (2006) 713-719
7. Milano M.T., Garofalo M.C., Chmura S.J., et al. Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques. Br J Radiol 79 (2006) 497-503
8. Hundahl S.A., Macdonald J.S., Benedetti J., et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 9 (2002) 278-286
9. Sasako M. Principles of surgical treatment for curable gastric cancer. J Clin Oncol 21 (2003) 274s-275s
10. Smalley S.R., Gunderson L., Tepper J., et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys 52 (2002) 283-293
11. Gunderson L.L., and Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8 (1982) 1-11
12. Hartgrink H.H., van de Velde C.J.H., Putter H., et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 22 (2004) 2069-2077
13. Nashimoto A., Nakajima T., Furukawa H., et al. Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 21 (2003) 2282-2287
14. Hayes N., Ng E.K.W., Raimes S.A., et al. Total gastrectomy with extended lymphadenectomy for "curable" stomach cancer: experience in a non-Japanese Asian center. J Am Coll Surg 118 (1999) 27-32
15. Hughes B.G., Yip D., Chao M., et al. Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience. Aust NZ J Surg 74 (2004) 951-956
16. Kim S., Lim D.H., Lee J., et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 63 (2005) 1279-1285
17. Chang ATY, Wong S, Ng WT, et al. Postoperative chemoradiation for gastric adenocarcinoma in Chinese population: acute toxicity, survival and predictors of outcome. Hong Kong College of Radiologists 14th Annual Scientific Meeting, 2006 (proffered paper ONC 4).
18. Siewert J.R., Bottcher K., Stein H.J., et al. Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer study. Ann Surg 228 (1998) 449-461
19. Kim S.H., Karpeh M.S., Klimstra D.S., et al. Effect of microscopic resection line disease on gastric cancer. J Gastrointest Surg 3 (1999) 24-33
20. Chan W.H., Wong W.K., Khin L.W., et al. Significance of a positive esophageal margin in stomach cancer. Aust NZ J Surg 70 (2000) 700-703
21. Hermans J., Bonenkamp J.J., Boon M.C., et al. Adjuvant therapy after curative resection for gastric cancer: a meta-analysis of randomized trials. J Clin Oncol 11 (1993) 1441-1447
22. Earle C., and Maroun J. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35 (1999) 1059-1064
23. Mari E., Floriani I., Tinazzi A., et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. Ann Oncol 11 (2000) 837-843
24. Janunger K.G., Hafstrom L., and Glimelius B. Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 168 (2002) 597-608
25. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
26. Pemberton L., Coote J., Perry L., et al. Adjuvant chemoradiotherapy for gastric carcinoma: dosimetric implications of conventional gastric bed irradiation and toxicity. Clin Oncol 18 (2006) 663-668
27. Rosu M., Dawson L.A., Balter J.M., et al. Alternations in normal liver doses due to organ motion. Int J Radiat Oncol Biol Phys 57 (2003) 1472-1479